Barrett Evans - 15 May 2025 Form 3 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Role
ex CEO, Director, 10%+ Owner
Signature
Barrett Evans
Issuer symbol
PTIX
Transactions as of
15 May 2025
Net transactions value
$0
Form type
3
Filing time
24 Oct 2025, 13:40:30 UTC
Previous filing
11 Aug 2021
Next filing
24 Oct 2025
SEC
View on sec.gov

Reporting Owners (3)

Name Relationship Address Signature Signature date CIK
EVANS BARRETT ex CEO, Director, 10%+ Owner 701 ANACAPA STREET, SUITE C, SANTA BARBARA Barrett Evans 23 Oct 2025 0001277242
EMC2 Capital LLC ex CEO, Director, 10%+ Owner 701 ANACAPA STREET, SUITE C, SANTA BARBARA Barrett Evans 23 Oct 2025 0001905629
Mammoth Crest Capital LLC ex CEO, Director, 10%+ Owner 701 ANACAPA STREET, SUITE C, SANTA BARBARA Barrett Evans 23 Oct 2025 0001877347

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PTIX Common Stock 16,233 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. F1
holding PTIX Preferred Stock Series C 787 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. F1
holding PTIX Preferred Stock Series C-1 131,034 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. F1
holding PTIX Preferred Stock Series D 1,000 15 May 2025 Direct F1
holding PTIX Preferred Stock Series D 4,498 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. F1
holding PTIX Preferred Stock Series D 1,000 15 May 2025 These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Evans was the CEO and is a Director of PTIX